Growth Metrics

Innoviva (INVA) Goodwill & Intangibles (2013 - 2026)

Innoviva posted quarterly Goodwill & Intangibles of $193.5 million for Q1 2026, down 30.79% year-on-year from $279.6 million in Q1 2025, and down 3.28% on a QoQ basis from $200.1 million in Q4 2025.

Innoviva (INVA) has 7 years of Goodwill & Intangibles data on file, last reported at $193.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Goodwill & Intangibles fell 30.79% year-over-year to $193.5 million; the trailing twelve-month figure through Mar 2026 stood at $193.5 million (down 30.79% YoY), and the FY2025 full-year result was $200.1 million, down 11.61% from the prior year.
  • Goodwill & Intangibles for Q1 2026 stood at $193.5 million, down from $200.1 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $285.2 million in Q4 2022 and bottomed at $105.0 million in Q2 2022.
  • The 5-year median for Goodwill & Intangibles is $241.8 million (2024), against an average of $232.5 million.
  • The widest annual swing landed in 2023, when Goodwill & Intangibles jumped 159.62%; it then tumbled 30.79% in 2026.
  • A 5-year view of Goodwill & Intangibles shows it stood at $285.2 million in 2022, then dropped by 3.37% to $275.6 million in 2023, then slipped by 17.87% to $226.3 million in 2024, then slipped by 11.61% to $200.1 million in 2025, then declined by 3.28% to $193.5 million in 2026.
  • The last three Goodwill & Intangibles figures came in at $193.5 million (Q1 2026), $200.1 million (Q4 2025), and $279.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 193.50 Mn
Dec 31, 2025 200.06 Mn
Sep 30, 2025 279.61 Mn
Jun 30, 2025 213.32 Mn
Mar 31, 2025 279.61 Mn
Dec 31, 2024 226.34 Mn
Sep 30, 2024 228.84 Mn
Jun 30, 2024 235.36 Mn
Mar 31, 2024 241.80 Mn
Dec 31, 2023 275.60 Mn
Sep 30, 2023 254.75 Mn
Jun 30, 2023 272.60 Mn
Mar 31, 2023 276.26 Mn
Dec 31, 2022 285.20 Mn
Sep 30, 2022 274.49 Mn
Jun 30, 2022 105.00 Mn
Mar 31, 2022 110.54 Mn
Sep 30, 2014 211.65 Mn
Jun 30, 2014 194.88 Mn
Mar 31, 2014 137.48 Mn
Dec 31, 2013 124.26 Mn
Sep 30, 2013 40.00 Mn
Jun 30, 2013 30.00 Mn